4//SEC Filing
Celator Pharmaceuticals Inc 4
Accession 0001192482-13-000152
CIK 0001327467operating
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:02 PM ET
Size
17.2 KB
Accession
0001192482-13-000152
Insider Transaction Report
Form 4
QUAKER BIO VENTURES LP
10% Owner
Transactions
- Other
Common Stock
2013-04-29+59,995→ 590,427 total(indirect: By Garden State Life Sciences Venture Fund, L.P.) - Other
Warrant
2013-04-29+30,708→ 30,708 totalExercise: $3.58From: 2013-04-29Exp: 2020-04-29→ Common Stock (30,708 underlying) - Other
Common Stock
2013-04-29+49,434→ 1,287,274 total - Other
Warrant
2013-04-29+35,737→ 35,737 total(indirect: By Garden State Life Sciences Venture Fund, L.P.)Exercise: $3.58From: 2013-04-29Exp: 2020-04-29→ Common Stock (35,737 underlying)
Holdings
- 31,908(indirect: By Garden State Life Sciences Venture Fund, L.P.)
Warrant
Exercise: $5.21From: 2012-08-28Exp: 2019-08-28→ Common Stock (31,908 underlying) - 27,418
Warrant
Exercise: $5.21From: 2012-08-28Exp: 2019-08-28→ Common Stock (27,418 underlying)
QUAKER BIOVENTURES CAPITAL LP
10% Owner
Transactions
- Other
Common Stock
2013-04-29+59,995→ 590,427 total(indirect: By Garden State Life Sciences Venture Fund, L.P.) - Other
Common Stock
2013-04-29+49,434→ 1,287,274 total - Other
Warrant
2013-04-29+30,708→ 30,708 totalExercise: $3.58From: 2013-04-29Exp: 2020-04-29→ Common Stock (30,708 underlying) - Other
Warrant
2013-04-29+35,737→ 35,737 total(indirect: By Garden State Life Sciences Venture Fund, L.P.)Exercise: $3.58From: 2013-04-29Exp: 2020-04-29→ Common Stock (35,737 underlying)
Holdings
- 27,418
Warrant
Exercise: $5.21From: 2012-08-28Exp: 2019-08-28→ Common Stock (27,418 underlying) - 31,908(indirect: By Garden State Life Sciences Venture Fund, L.P.)
Warrant
Exercise: $5.21From: 2012-08-28Exp: 2019-08-28→ Common Stock (31,908 underlying)
Footnotes (6)
- [F1]Quaker BioVentures, L.P. ("Quaker") was issued these securities as an anti-dilution adjustment with respect to previously acquired securities.
- [F2]These securities are owned of record by Quaker. Quaker BioVentures Capital, L.P. ("Quaker Capital") is the general partner of Quaker, has voting and dispositive power over the shares held by Quaker, and thus may be deemed to beneficially own these securities. Voting and investment determinations made by Quaker Capital with respect to the shares held by Quaker are made by an investment committee of Quaker Partners. Quaker Capital disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- [F3]Garden State Life Sciences Venture Fund, L.P. ("Garden State") was issued these securities as an anti-dilution adjustment with respect to previously acquired securities.
- [F4]These securities are owned of record by Garden State. Quaker Capital is the general partner of Garden State, has voting and dispositive power over the shares held by Garden State, and thus may be deemed to beneficially own these securities. Voting and investment determinations made by Quaker Capital with respect to the shares held by Garden State are made by an investment committee of Quaker Partners. Quaker disclaims beneficial ownership of these securities, and Quaker Capital disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- [F5]Quaker was issued a warrant to purchase 16,391 shares of common stock on August 28, 2012. The number of shares that may be purchased upon exercise of this warrant was increased to 27,418 shares of common stock as part of an anti-dilution adjustment.
- [F6]Garden State was issued a warrant to purchase 19,076 shares of common stock on August 28, 2012. The number of shares that may be purcased upon exercise of this warrant was increased to 31,908 shares of common stock as part of an anti-dilution adjustment.
Documents
Issuer
Celator Pharmaceuticals Inc
CIK 0001327467
Entity typeoperating
Related Parties
1- filerCIK 0001327467
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:02 PM ET
- Size
- 17.2 KB